Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
NEW YORK–(BUSINESS WIRE)–Kroll Bond Rating Agency (KBRA) releases its inaugural Business Development Company (BDC) Ratings Compendium, which analyzes the 2Q results of BDCs within the KBRA universe.
Themes discussed in the Compendium include:
The Compendium includes second-quarter 2019 updates in KBRA’s rated universe, focusing on key performance and credit metrics, along with medians of key ratios.
To access the report, click here.
Related Publications: (available at www.kbra.com)
CONNECT WITH KBRA
Twitter
LinkedIn
Download the iOS App
YouTube
About KBRA and KBRA Europe
KBRA is a full-service credit rating agency registered with the U.S. Securities and Exchange Commission as an NRSRO. In addition, KBRA is designated as a designated rating organization by the Ontario Securities Commission for issuers of asset-backed securities to file a short form prospectus or shelf prospectus. KBRA is also recognized by the National Association of Insurance Commissioners as a Credit Rating Provider and is a certified Credit Rating Agency (CRA) by the European Securities and Markets Authority (ESMA). Kroll Bond Rating Agency Europe Limited is registered with ESMA as a CRA.
Contacts
Analytical:
Teri Seelig, Director
(646) 731-2386
tseelig@kbra.com
Boris Alishayev, Director
(646) 731-2484
balishayev@kbra.com
Thomas Moore, Senior Analyst
(646) 731-3375
tmoore@kbra.com
Marjan Riggi, Senior Managing Director
(646) 731-2354
mriggi@kbra.com
AI Nose Expands from Semiconductor Facilities into Frontline Healthcare Infrastructure HOUSTON, TX / ACCESS Newswire…
MANASSAS, VA / ACCESS Newswire / June 1, 2026 / Rescue Intellitech, a leader in…
SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / RF Industries, Ltd, (NASDAQ:RFIL),…
TORONTO, ON / ACCESS Newswire / June 1, 2026 / Datametrex AI Limited (the "Company"…
TUCSON, AZ / ACCESS Newswire / June 1, 2026 / Applied Energetics, Inc. (OTCQB:AERG), a…
At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran…